Over the past 5 years, billionaire Mukesh Ambani’s Reliance Industries Ltd (RIL) spent $13 billion on acquisitions, marking a strategic shift away from its traditional oil and petrochemicals businesses into clean energy and consumer-focused sectors. is The acquisition encompasses new energy, telecom, retail, and media businesses, with a notable recent addition to its digital healthcare ecosystem.
Last week, RIL acquired Karkinos Healthcare for Rs 375 crore, strengthening its presence in the diagnostic and digital healthcare sectors.
According to a report by Morgan Stanley “Over the past five years, RIL has announced acquisitions worth $13 billion with 14 percent in new energy, 48 percent in technology, media and telecommunications (TMT), 9 percent in retail, and There has been a rapid increase in health care.”
The report also highlighted that $6 billion of the total was spent on media and education acquisitions, $2.6 billion on telecom and Internet ventures, $1.7 billion on new energy, and $1.14 billion on retail. . The most significant acquisition in the past five years was the $981 million purchase of Hathaway Cable and Datacom, local cable TV and Internet service providers. RIL also spent $771 million to acquire Norwegian solar panel maker REC Solar Holdings and $767 million to buy search and database firm JustDial.
The recent acquisition of Carcinos Healthcare, which focuses on advanced technology-based solutions for early detection and management of cancer, adds to RIL’s growing healthcare portfolio. Karkinos aims to act as a care partner during a patient’s cancer treatment, joining previous investments such as HAGI, Netmeds, and Strand Life Science.
Founded in 2020, Karkinos had a turnover of Rs 22 crore in the financial year 2022-23. The company collaborates with around 60 hospitals and is setting up a 150-bed multi-specialty cancer hospital in Imphal, Manipur. It offers a range of services including oncology testing, radiation therapy, and advanced cancer care diagnostics, all at competitive prices aimed at improving access to effective cancer treatment.
Investors in Karkinos include Tata Group, Rakuten, Mayo Clinic, and Hero Enterprise. As part of its strategic vision, RIL leverages its technological expertise and extensive distribution networks to create integrated healthcare systems, digital health platforms, telemedicine services, and innovative healthcare delivery models. Intends to take advantage.